-
2 weeks ago | 
nature.com | Valentín Fuster |Ik-Kyung Jang
AbstractOver the past two decades, studies with serial coronary imaging have consistently shown favorable changes in plaque phenotype in response to lipid-lowering therapy (LLT). Here, we review these studies, which had varied follow-up periods, to examine the time course of changes in plaque phenotype. The plaque response to LLT appears to start with the thickening of the fibrous cap, followed by a decrease in lipid components and ultimately a regression in plaque volume.
-
2 months ago | 
jacc.org | Byrne R.A |Coughlan J.J |Valentín Fuster |Bhatt D.L
IntroductionClinical practice guidelines are among the most impactful documents worldwide. Their impact comes not only from the vast readership and extremely high quotation, but more importantly from the undoubtful influence on patient care. The lives of millions of people around the world benefit from implementing the recommendations presented in guidelines.
-
Mar 10, 2025 | 
nature.com | Valentín Fuster
AbstractCardiovascular disease (CVD) has achieved pandemic proportions and is currently the leading cause of death worldwide. Barriers to optimal secondary cardiovascular prevention include lack of access to chronic treatment as well as low adherence in those who receive these treatments. The polypill represents a simple, cost-effective, scalable strategy to improve access and adherence to medication and effectively bridge the current gap in secondary prevention of CVD.
-
Nov 29, 2024 | 
radcliffecardiology.com | Dipti Itchhaporia |Valentín Fuster |Rosa Lázaro-García |Javier Goicolea-Ruigómez
Video Published: Views: 5 Likes: 0 Average (ratings) In this exclusive episode of the "Innovations in Cardiology" podcast series, host Dr Dipti Itchhaporia, past president of the American College of Cardiology, delves into the latest advancements in cardiovascular health.
-
Nov 26, 2024 | 
sabervivirtv.com | Charo Sierra |Francisco Marín |Soledad Lopez |Valentín Fuster
La investigación en cardiología es una de las ramas de la medicina más avanzadas. Prácticamente hay tratamiento para todo tipo de dolencias. Sin embargo, no se había conseguido mejorar y acelerar la regeneración de las células del corazón. Cuando el corazón está dañado, por ejemplo tras sufrir un infarto, o cuando envejece, pierde fuerza. Se produce una insuficiencia cardiaca. El corazón es un músculo. Ese músculo, que se contrae y bombea la sangre, ya no bombea bien.
-
Nov 20, 2024 | 
sabervivirtv.com | Valentín Fuster
El cardiólogo Valentí Fuster ha llegado a los 81 años trabajando intensamente y con buena salud. No hace sino seguir las recomendaciones que él mismo ofrece a todos sus pacientes. Seguir poniendo entusiasmo e ilusión en sus objetivos es fundamental para trabajar. Y levantarse cada día e ir a trabajar es útil para mantener una buena salud. No tener objetivos en tu vida, un propósito afecta al bienestar.
-
Aug 30, 2024 | 
nature.com | Miriam Díez-Díez |Ana Quintas |Antonio J. Quesada |Ana Dopazo |Fátima Sánchez-Cabo |Borja Ibáñez | +3 more
AbstractClonal hematopoiesis, a condition in which acquired somatic mutations in hematopoietic stem cells lead to the outgrowth of a mutant hematopoietic clone, is associated with a higher risk of hematological cancer and a growing list of nonhematological disorders, most notably atherosclerosis and associated cardiovascular disease. However, whether accelerated atherosclerosis is a cause or a consequence of clonal hematopoiesis remains a matter of debate.
-
Jun 4, 2024 | 
jacc.org | Valentín Fuster |Ana Garcia-Alvarez |Ana Devesa |Virginia Mass
IntroductionCardiovascular disease (CVD) is the leading cause of death worldwide,1 and the clinical manifestations of the disease are usually preceded by many years by the underlying process of atherosclerosis.
-
Feb 2, 2024 | 
jacc.org | Larry M. Baddour |Valentín Fuster
References1. "2023 ESC Guidelines for the management of endocarditis". Eur Heart J . 2023;44:39: 3948-4042. 2. "Update on cardiovascular implantable electronic device infections and their prevention, diagnosis, and management: a Scientific Statement from the American Heart Association". Circulation . 2024;149:2: e201-e216. 3. "Infective endocarditis involving implanted cardiac electronic devices: JACC Focus Seminar 1/4". J Am Coll Cardiol . 2024;83:14: 1326-1337. 4.
-
Feb 1, 2024 | 
jacc.org | Valentín Fuster
References1. "Cellular senescence as a targetable risk factor for cardiovascular diseases". J Am Coll Cardiol Basic Trans Science . Published online April8, 2024. 10.1016/j.jacbts.2023.12.003. 2. "Aging in heart failure: embracing biology over chronology". J Am Coll Cardiol HF . Published online April8, 2024. 10.1016/j.jchf.2024.02.021. 3. "Noninvasive techniques for tracking biological aging of the cardiovascular system". J Am Coll Cardiol Img . Published online April8, 2024. 10.1016/j.jcmg.2024.03.001. 4.
